Bendamustine can severely impair T-cell immunity against cytomegalovirus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bendamustine can severely impair T-cell immunity against cytomegalovirus

Published:2012-11-15 Issue:6 Volume:54 Page:1327-1328
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hosoda Toru,Yokoyama Akihiro,Yoneda Mie,Yamamoto Ryusuke,Ohashi Kota,Kagoo Toshiya,Ueno Hironori,Boku Saigen,Yano Takahiro

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.739285

Reference4 articles.

1. Tetramer-based quantification of cytomegalovirus (CMV)–specific CD8+ T lymphocytes in T-cell–depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

2. Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

3. Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection risk and antimicrobial prophylaxis in bendamustine‐treated patients with indolent non‐Hodgkin lymphoma: An Australasian Lymphoma Alliance study;British Journal of Haematology;2024-03-14

2. Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience;Leukemia & Lymphoma;2022-10-12

3. Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel;Leukemia & Lymphoma;2022-09-16

4. Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections;Hematology;2022-05-11

5. Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab;Hematology;2022-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3